Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment

被引:33
作者
Fannon, M
Forsten-Williams, K
Dowd, CJ
Freedman, DA
Folkman, J
Nugent, MA
机构
[1] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA
[4] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
[5] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA
关键词
VEGF; endothelial cell; bFGF; heparin binding; computational model;
D O I
10.1096/fj.02-0935fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aqueous humor is a clear fluid, primarily a blood filtrate, which circulates through the anterior chamber of the eye and bathes the cornea. We explored the possibility that components in the aqueous humor play a direct part in maintaining the avascular environment of the cornea. We report here that heparan sulfate proteoglycan (HSPG) was found in bovine aqueous humor and that it directly inhibits binding of basic fibroblast growth factor and vascular endothelial growth factor to cell-surface heparan sulfate. We demonstrate that this holds true for all heparin binding proteins tested but not for epidermal growth factor, which does not bind heparin. Furthermore, we show, with mathematical modeling, that the concentration of HSPG in aqueous humor ( 4 mug/ml), when combined with the clearance of aqueous humor from the eye due to circulation, is sufficient to block the binding of heparin binding growth factors to corneal endothelium. This mechanism suggests a physiological process to control bioavailability of angiogenic growth factors in the cornea.
引用
收藏
页码:902 / +
页数:20
相关论文
共 50 条
[1]  
AUSPRUNK DH, 1978, LAB INVEST, V38, P284
[2]   Characterization of proteoglycans synthesized by cultured corneal fibroblasts in response to transforming growth factor β and fetal calf serum [J].
Brown, CT ;
Nugent, MA ;
Lau, FW ;
Trinkaus-Randall, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7111-7119
[3]   NEOVASCULARIZATION AND ITS ROLE IN THE OSTEOARTHRITIC PROCESS [J].
BROWN, RA ;
WEISS, JB .
ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (11) :881-885
[4]  
BRUBAKER RF, 1991, INVEST OPHTH VIS SCI, V32, P3145
[5]   BINDING AND INTERNALIZATION OF HEPARIN BY VASCULAR SMOOTH-MUSCLE CELLS [J].
CASTELLOT, JJ ;
WONG, K ;
HERMAN, B ;
HOOVER, RL ;
ALBERTINI, DF ;
WRIGHT, TC ;
CALEB, BL ;
KARNOVSKY, MJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 1985, 124 (01) :13-20
[6]  
Collen A, 2000, CANCER RES, V60, P6196
[7]   ESTABLISHMENT OF A CELL-LINE FROM THE EHS TUMOR - BIOSYNTHESIS OF BASEMENT-MEMBRANE CONSTITUENTS AND CHARACTERIZATION OF A HYBRID PROTEOGLYCAN CONTAINING HEPARAN AND CHONDROITIN SULFATE CHAINS [J].
DANIELSON, KG ;
MARTINEZHERNANDEZ, A ;
HASSELL, JR ;
IOZZO, RV .
MATRIX, 1992, 12 (01) :22-35
[8]   Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding [J].
Dowd, CJ ;
Cooney, CL ;
Nugent, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :5236-5244
[9]   Potentiation and inhibition of bFGF binding by heparin: A model for regulation of cellular response [J].
Fannon, M ;
Forsten, KE ;
Nugent, MA .
BIOCHEMISTRY, 2000, 39 (06) :1434-1445
[10]   Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate [J].
Fannon, M ;
Nugent, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) :17949-17956